SecBot SecBot
Insider Buy ·Filed Aug 12, 2026

PFE

PFIZER INC
BULLISH
Impact 5/10
Horizonweeks Processed3mo ago SEC0001225208-26-007083
Insider cluster: 1 insiders, $1.0M total
Actionable Insight ▲ Bullish

CEO's first open-market buy in this window after strong Q2 results and guidance raise is a credible bullish signal consistent with insider-literature patterns. However, the buy size is negligible relative to PFE's $152.7B market cap, treat as a conviction signal, not a liquidity event. Monitor for additional insider buys (especially C-suite) and any share buyback program announcements that could validate the signal at scale. The stock's current price of $26.87 is essentially flat to Bourla's purchase price, limited immediate catalyst.

DirectionBullish
Confidencemedium
Horizonweeks

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$26.80
T+0 close · Aug 12, 2026 · via day close
Latest settled
+9.66%
T+60 · $29.39
Vs SPY
+15.14%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 13 $26.80entry
  2. T+1 · 3mo ago −0.04%α +0.16% · $26.79
  3. T+5 · 3mo ago +3.69%α +5.66% · $27.79
  4. T+20 · 2mo ago +3.43%α +5.18% · $27.72
  5. T+60 · 10d ago +9.66%α +15.14% · $29.39
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Pfizer Chairman & CEO Albert Bourla made an open-market purchase of $1.0M worth of shares at $26.34 on August 12, 2026, his first open-market buy in the reported window. This purchase follows a strong Q2 earnings beat (12.9% on adjusted EPS) and a raised revenue guidance midpoint by $500M, signaling insider conviction that the stock is undervalued despite GAAP net loss from $4.3B in intangible asset impairments. At $152.7B market cap, the $1.0M buy represents ~0.001% of market cap, proportionally tiny, but as a standalone CEO conviction buy backed by solid operational results, it carries meaningful signal per insider-trading literature.

Key Financial Metrics

Direction
buying
Total Value
$1.0M
Insiders
1

Key Facts

  • Chairman & CEO Albert Bourla purchased 38,000 shares at $26.34 for total of $1,000,920 on August 12, 2026
  • Purchase is an open-market buy (SEC code P), not a grant or exercise, CEO is deploying personal capital
  • Purchase comes 8 days after Pfizer reported Q2 2026 adjusted EPS beat of 12.9% ($0.77 vs $0.68 consensus) and raised FY2026 revenue guidance midpoint by $500M to $60.5-$62.5B
  • Bourla also received a 22-share grant on August 14 ($589), de minimis, but consistent with normal administrative pattern
  • Pfizer has $152.7B market cap, the $1.0M open-market purchase represents ~0.001% of market cap, proportionally tiny
  • Recent insider activity (30d): 3 buys totaling $3.0M and 1 sell of $83K, net buying trend

Financial Impact

CEO open-market purchase of $1.0M at $26.34 per share, representing ~0.001% of market cap

Risk Factors

  • Purchase is proportionally trivial (~0.001% of market cap), may not reflect a material conviction view
  • Pfizer reported a GAAP net loss of $0.04 per share due to $4.3B in non-cash intangible impairments, underlying earnings quality is mixed
  • No 10b5-1 plan exclusion available, this buy could be pre-planned, though open-market purchases are less likely to be 10b5-1 sales

Market Snapshot

Price
$26.87
Volume
100
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
39% bullish (36 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
INSIDER-BUY Data (Synthetic)0001225208-26-007083

Track record

21 reports on PFE

Performance horizon

4 of 7 bullish or bearish reports moved the stock their way by T+60. Best: +17.28% at T+60 after the Aug 4, 2026 report. 6 of 8 went positive at some point.

Filters
  1. Nov 3, 202612d ago 8-K Neutral 2/10 Entry $30.79 Now $28.88 −6.22% settles Feb 2
  2. Nov 3, 202613d ago 8-K Bullish 6/10 Entry $30.00 Now $28.88 −3.75% settles Feb 1
  3. Oct 30, 202617d ago Court Ruling Neutral 2/10 Entry $30.67 Now $28.88 −5.85% settles Jan 29
  4. Oct 23, 202624d ago Institutional Cluster Mixed 3/10 Entry $30.03 Now $28.88 −3.84% settles Jan 21
  5. Aug 13, 202613w ago Court Ruling Neutral 1/10 Entry $26.79 to $29.23 Now $28.88 +7.79% ▲ +9.11% +12.15% vs SPY
  6. Aug 12, 202613w ago Insider Buy Bullish 5/10 Viewing Entry $26.80 to $29.39 Now $28.88 +7.75% ▲ +9.66% +15.14% vs SPY
  7. Aug 12, 202613w ago Insider Cluster Bullish 6/10 Entry $26.80 to $29.39 Now $28.88 +7.75% ▲ +9.66% +15.14% vs SPY
  8. Aug 6, 202614w ago Insider Cluster Bullish 4/10 Entry $26.20 to $30.52 Now $28.88 +10.21% ▲ +16.49% +18.16% vs SPY
  9. Aug 5, 202614w ago Insider Buy Bullish 5/10 Entry $26.20 to $30.52 Now $28.88 +10.21% ▲ +16.49% +18.16% vs SPY
  10. Aug 5, 202614w ago Insider Cluster Neutral 3/10 Entry $26.20 to $30.52 Now $28.88 +10.21% ▲ +16.49% +18.16% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens Tue (17h 20m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 17, 2026